Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 59.5 | 78 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 57.0 | 54 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 51.0 | 59 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 65.5 | 66 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 66.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 1 | FGF Basic | 56.0 | 49 | |
N2586 | PI103 | 0.1 | uM | 1 | FGF Basic | 42.0 | 73 | ||||
RA2159 | IL-6 | 100 | ug/mL | 1 | FGF Basic | 46.0 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 42.0 | 63 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 45.0 | 73 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 56.0 | 88 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 43.0 | 71 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 49.5 | 68 | |
RA2159 | Sigma A6730 | 3.0 | uM | 1 | FGF Basic | 37.0 | 57 | ||||
N2586 | IL-6 | 100 | ug/mL | 1 | FGF Basic | 52.0 | 86 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 39.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 47.5 | 44 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 52.5 | 48 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 39.0 | 62 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 1 | FGF Basic | 46.5 | 56 | |
N2586 | Sigma A6730 | 3.0 | uM | 1 | FGF Basic | 46.0 | 54 | ||||
RA2159 | IL-17A | 100 | ng/mL | 1 | FGF Basic | 38.5 | 68 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-17A | 100 | ng/mL | 1 | FGF Basic | 42.5 | 72 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | FGF Basic | 37.0 | 70 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-17A | 100 | ng/mL | 1 | FGF Basic | 43.0 | 61 |